We have previously reported that inhibiting MAPK4 (knockdown or knockout) is very effective in suppressing the growth of various MAPK4-high cancer cells, including breast cancer, prostate cancer, non-small cell lung cancer, and colon cancer [3,4,18]. Here, MAPK4 is linked to prostate cancer.